ES2142490T3 - Ciclopeptolidos. - Google Patents

Ciclopeptolidos.

Info

Publication number
ES2142490T3
ES2142490T3 ES95928473T ES95928473T ES2142490T3 ES 2142490 T3 ES2142490 T3 ES 2142490T3 ES 95928473 T ES95928473 T ES 95928473T ES 95928473 T ES95928473 T ES 95928473T ES 2142490 T3 ES2142490 T3 ES 2142490T3
Authority
ES
Spain
Prior art keywords
cyclopeptolids
leu
expression
adhesion molecules
xey
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95928473T
Other languages
English (en)
Inventor
Michael Morris Dreyfuss
Carolyn Ann Foster
Hans-Ulrich Naegeli
Berndt Oberhauser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9415168A external-priority patent/GB9415168D0/en
Priority claimed from GBGB9504332.9A external-priority patent/GB9504332D0/en
Application filed by Novartis AG filed Critical Novartis AG
Application granted granted Critical
Publication of ES2142490T3 publication Critical patent/ES2142490T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungi isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • AIDS & HIV (AREA)

Abstract

CICLOPEPTOLIDOS DE FORMULA (I), EN LA QUE A, B, R 1 LEU, LEU, C, X E Y, SON COMO SE DEFINEN A CONTINUACION, SON INHIBIDORES DE LA EXPRESION DE LAS MOLECULAS DE ADHESION Y SON UTILES POR TANTO EN EL TRATAMIENTO DE ENFERMEDADES INFLAMATORIAS Y OTRAS, QUE SE DEBEN A NIVELES INCREMENTADOS DE EXPRESION DE LAS MOLECULAS DE ADHESION.
ES95928473T 1994-07-27 1995-07-26 Ciclopeptolidos. Expired - Lifetime ES2142490T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9415168A GB9415168D0 (en) 1994-07-27 1994-07-27 Organic compounds
GBGB9504332.9A GB9504332D0 (en) 1995-03-03 1995-03-03 Organic compounds

Publications (1)

Publication Number Publication Date
ES2142490T3 true ES2142490T3 (es) 2000-04-16

Family

ID=26305345

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95928473T Expired - Lifetime ES2142490T3 (es) 1994-07-27 1995-07-26 Ciclopeptolidos.

Country Status (25)

Country Link
US (1) US6013627A (es)
EP (1) EP0775158B1 (es)
JP (1) JP3425763B2 (es)
KR (1) KR100378974B1 (es)
CN (1) CN1116304C (es)
AT (1) ATE187461T1 (es)
AU (1) AU702332B2 (es)
BR (1) BR9508342A (es)
CA (1) CA2192786C (es)
CY (1) CY2225B1 (es)
CZ (1) CZ289311B6 (es)
DE (1) DE69513837T2 (es)
DK (1) DK0775158T3 (es)
ES (1) ES2142490T3 (es)
FI (1) FI970279A0 (es)
GR (1) GR3032698T3 (es)
HU (1) HUT77388A (es)
MX (1) MX9606494A (es)
NO (1) NO970340L (es)
NZ (1) NZ291168A (es)
PL (1) PL181990B1 (es)
PT (1) PT775158E (es)
RU (1) RU2155772C2 (es)
SK (1) SK11797A3 (es)
WO (1) WO1996003430A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187757B1 (en) 1995-06-07 2001-02-13 Ariad Pharmaceuticals, Inc. Regulation of biological events using novel compounds
US6011136A (en) * 1995-11-21 2000-01-04 Novartis Ag Cyclopeptolides
WO1999014082A1 (en) 1996-09-18 1999-03-25 Minnesota Mining And Manufacturing Company Adhesively-bonded inflatable restraint and method of making
US6365619B1 (en) 1999-07-22 2002-04-02 Novartis Ag Treatment of arteriosclerosis
AU783158B2 (en) * 1999-08-24 2005-09-29 Ariad Pharmaceuticals, Inc. 28-epirapalogs
US7067526B1 (en) 1999-08-24 2006-06-27 Ariad Gene Therapeutics, Inc. 28-epirapalogs
WO2002034283A2 (en) * 2000-10-27 2002-05-02 Novartis Ag Vegh inhibitors and their use
GB0028367D0 (en) * 2000-11-21 2001-01-03 Celltech Chiroscience Ltd Chemical compounds
GB0101598D0 (en) * 2001-01-22 2001-03-07 Novartis Ag Organic compounds
EP2181704B1 (en) 2002-12-30 2015-05-06 Angiotech International Ag Drug delivery from rapid gelling polymer composition
WO2009089549A1 (en) 2008-01-11 2009-07-16 Massachusetts Eye & Ear Infirmary Conditional-stop dimerizable caspase transgenic animals
US9593356B2 (en) 2013-06-11 2017-03-14 Takara Bio Usa, Inc. Protein enriched microvesicles and methods of making and using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4425428A (en) * 1982-04-08 1984-01-10 Monsanto Company Novel peptide and peptolide substrates for mammalian collagenase
US4443367A (en) * 1982-04-08 1984-04-17 Monsanto Company Peptide and peptolide substrates for mammalian collagenase
EP0296123B1 (en) * 1987-06-19 1994-08-31 Sandoz Ag Cyclic peptolides
DE3832059A1 (de) * 1988-09-21 1990-03-29 Howaldtswerke Deutsche Werft Tauchtiefengesteuerte ausblasventil-einrichtung
DE3832362A1 (de) * 1988-09-23 1990-03-29 Sandoz Ag Neue cyclopeptolide, verfahren zu ihrer herstellung und ihre verwendung

Also Published As

Publication number Publication date
HK1014011A1 (en) 1999-09-17
ATE187461T1 (de) 1999-12-15
PL317349A1 (en) 1997-04-01
GR3032698T3 (en) 2000-06-30
FI970279A7 (fi) 1997-01-23
EP0775158B1 (en) 1999-12-08
FI970279L (fi) 1997-01-23
CN1154705A (zh) 1997-07-16
NO970340D0 (no) 1997-01-27
CA2192786C (en) 2009-06-16
SK11797A3 (en) 1997-07-09
NO970340L (no) 1997-01-27
AU3222195A (en) 1996-02-22
MX9606494A (es) 1997-03-29
EP0775158A1 (en) 1997-05-28
JPH10504540A (ja) 1998-05-06
CN1116304C (zh) 2003-07-30
PT775158E (pt) 2000-05-31
CY2225B1 (en) 2003-04-18
FI970279A0 (fi) 1997-01-23
DE69513837D1 (de) 2000-01-13
DK0775158T3 (da) 2000-05-22
US6013627A (en) 2000-01-11
HUT77388A (hu) 1998-04-28
AU702332B2 (en) 1999-02-18
NZ291168A (en) 1998-06-26
BR9508342A (pt) 1997-10-21
RU2155772C2 (ru) 2000-09-10
WO1996003430A1 (en) 1996-02-08
CZ289311B6 (cs) 2001-12-12
JP3425763B2 (ja) 2003-07-14
KR100378974B1 (ko) 2003-10-08
CZ22197A3 (en) 1997-05-14
DE69513837T2 (de) 2000-05-18
PL181990B1 (pl) 2001-10-31
CA2192786A1 (en) 1996-02-08

Similar Documents

Publication Publication Date Title
ES2106965T3 (es) Nuevas 4-aza-5alfa-androstan-3-onas 7beta-sustituidas como inhibidores de 5alfa-reductasa.
ES2138622T3 (es) Derivados de mercaptoacetilamido piridazo(1,2-a)(1,2)diazepina utilizados como inhibidores de encefalinasa y eca.
UY26249A1 (es) Moléculas pequenas útiles en el tratamiento de las enfermedades inflamatorias ley 17164 art. 127
ES2114870T3 (es) Nuevos derivados de mercaptoacetilamida utiles como inhibidores de encefalinasa y eca.
ES2106112T3 (es) Derivados de indano-2-mercaptoacetilamida con una actividad inhibidora de encefalinasa y de ace.
ES2128283T1 (es) Profarmacos de inhibidores de trombina.
ES2172069T3 (es) Derivado tetrapeptidico.
MX9102407A (es) 4 arilpiperazinas y 4-arilpiperidinas novedosas.
ES2163034T3 (es) Composiciones micelares de copolimeros de bloque de polieter, para la objetivizacion de agentes biologicos como diana.
ES2142490T3 (es) Ciclopeptolidos.
ES2150705T3 (es) Derivados de ester de nitrito esteroideos utiles como farmacos antiinflamatorios.
PT1144365E (pt) Inibidores da adesao de celulas mediada por alfa4beta1
ES2082012T3 (es) Inhibidores de la enzima beta-liasa de aminoacido como desodorantes.
ES2151168T3 (es) N-(2,4-dioxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3-il)-3-amidas.
ES2131313T3 (es) Derivados de acido nipecotico como compuestos antitromboticos.
ES2064119T3 (es) Nuevos derivados de aminobenzosultam como inhibidores de la lipoxigenasa.
PT804465E (pt) Novos inibidores da elastase
ES2054901T3 (es) Nuevos compuestos de n-ariltetrahidroftalimida.
ES2159054T3 (es) Compuestos di-terc-butil-fenolicos que contienen azufre utiles como agentes antiinflamatorios.
ES2140672T3 (es) Compuestos biciclicos sustituidos, fusionados y puentes utilizados como agentes terapeuticos.
ATE330604T1 (de) Behandlung von manischen erkrankungen
ES2189206T3 (es) Beta-alcoxiacrilatos contra la malaria.
ES2103131T3 (es) Nuevos agentes de nucleosido carbociclico utiles como inhibidores selectivos de citoquinas proinflamatorias.
ATE117549T1 (de) Lysyl-oxidase-inhibitoren.
AR012286A1 (es) Ciclopeptolidos

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 775158

Country of ref document: ES